Atlas Trials

Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET

Clinical trial NCT00583323 · COMPLETED

Trial details

NCT number
NCT00583323
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma
Start date
2003-02-01
Primary completion
2005-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.